BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21164353)

  • 1. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
    Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.
    Mourez T; Delaugerre C; Vray M; Lemée V; Simon F; Plantier JC
    J Clin Virol; 2015 Oct; 71():76-81. PubMed ID: 26318912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
    De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
    J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.
    Amendola A; Marsella P; Bloisi M; Forbici F; Angeletti C; Capobianchi MR
    J Clin Microbiol; 2014 Jun; 52(6):2019-26. PubMed ID: 24671791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load.
    Adams P; Vancutsem E; Nicolaizeau C; Servais JY; Piérard D; François JH; Schneider T; Paxinos EE; Marins EG; Canchola JA; Seguin-Devaux C
    J Clin Virol; 2019 May; 114():43-49. PubMed ID: 30991164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.
    Xu S; Song A; Nie J; Li X; Wang Y
    Mol Diagn Ther; 2010 Oct; 14(5):305-16. PubMed ID: 21053996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece.
    Katsoulidou A; Rokka C; Issaris C; Haida C; Tzannis K; Sypsa V; Detsika M; Paraskevis D; Hatzakis A
    Virol J; 2011 Jan; 8():10. PubMed ID: 21219667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
    Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
    Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
    Taylor N; Grabmeier-Pfistershammer K; Egle A; Greil R; Rieger A; Ledergerber B; Oberkofler H
    PLoS One; 2013; 8(8):e74024. PubMed ID: 24023696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
    Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
    J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
    Pyne MT; Brown KL; Hillyard DR
    J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay.
    van Rensburg EJ; Tait K; Watt A; Schall R
    J Clin Microbiol; 2011 Jan; 49(1):377-9. PubMed ID: 20980564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.
    Scott LE; Noble LD; Moloi J; Erasmus L; Venter WD; Stevens W
    J Clin Microbiol; 2009 Jul; 47(7):2209-17. PubMed ID: 19420172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance Evaluation of the Bioneer AccuPower® HIV-1 Quantitative RT-PCR kit: Comparison with the Roche COBAS® AmpliPrep/COBAS TaqMan® HIV-1 Test Ver.2.0 for Quantification of HIV-1 Viral Load in Indonesia.
    Kosasih AS; Sugiarto C; Hayuanta HH; Juhaendi R; Setiawan L
    Asian Pac J Allergy Immunol; 2018 Jun; 36(2):120-125. PubMed ID: 28802027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.